Eburicoic acid
Eburicoic acid (ZINC4655149) demonstrates hepatoprotective effects against CCl4-induced damage through its anti-inflammatory and antioxidant properties. This activity supports its investigation in liver disease research, including studies on hepatotoxicity and potential anti-liver cancer applications in both in vitro and in vivo models.
Product Specifications
CAS Number
560-66-7
Product Name Alternative
CCL4, Antioxidant, Immunologyrelated, Immunology related, inflammation, Inflammation related, Inflammationrelated, NOSynthase, NOS, MFCD00238594, MFCD-00238594, MFCD 00238594, NO Synthase, Eburicoic acid, Eburicoicacid, TNF-α, ZINC 4655149, ZINC4655149, ZINC-4655149
Field of Research
Cell Biology, Immunology & Inflammation, Infectious Disease & Virology, Metabolism Research, Pharmacology & Drug Discovery
Purity
97.87% (May vary between batches)
Smiles
[H][C@@]1 (CC[C@@]2 (C) C3=C (CC[C@]12C) [C@@]1 (C) CC[C@H] (O) C (C) (C) [C@]1 ([H]) CC3) [C@@H] (CCC (=C) C (C) C) C (O) =O
Molecular Formula
C31H50O3
Molecular Weight
470.73
Storage Conditions
Store at low temperature, keep away from direct sunlight, store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15099118 1 Vial
Lentiviral human GABRA5 shRNA (UAS) - Lentiviral human GABRA5 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 